Core Insights - The global smartphone CMOS image sensor (CIS) shipment is expected to grow by 2% year-on-year in 2024, reaching 4.4 billion units [1][4] - Sony remains the market leader, followed by GalaxyCore and OmniVision [1][4] Group 1: Market Predictions - The average number of cameras per smartphone is projected to decrease from 3.8 in 2023 to 3.7 in 2024 [4] - The increase in CIS shipments is driven by a recovery in end-market demand [4] - The average selling price (ASP) of CIS is expected to rise due to advancements in technologies like LOFIC and multispectral imaging [6] Group 2: Company Performances - Sony's shipment volume has slightly increased due to improved production yields and higher demand for premium smartphones [4] - GalaxyCore's shipment volume has surged by 34% year-on-year, attributed to its cost efficiency and transition to a light wafer fab model [4][5] - OmniVision anticipates a 14% year-on-year growth in shipments, supported by the success of its 50MP image sensor [5] Group 3: Market Dynamics - SK Hynix plans to exit the CIS business by March 2025, potentially creating new growth opportunities for Chinese suppliers like GalaxyCore and OmniVision [5] - Geopolitical tensions and macroeconomic uncertainties are expected to pose challenges to the global smartphone market, leading to a slight decline in CIS shipments in 2025 [6]

本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 一、 召开会议的基本情况 证券代码：688728 证券简称：格科微 公告编号：2025-019 格科微有限公司 关于召开2024年年度股东大会的通知 （一） 股东大会类型和届次 2024年年度股东大会 （二） 股东大会召集人：董事会 （三） 投票方式：本次股东大会所采用的表决方式是现场投票和网络投票相结 合的方式 （四） 现场会议召开的日期、时间和地点 股东大会召开日期：2025年6月13日 本次股东大会采用的网络投票系统：上海证券交易所股东大会网络投票 系统 召开日期时间：2025 年 6 月 13 日 14 点 00 分 召开地点：中国（上海）自由贸易试验区盛夏路 560 号 2 幢第 11 层 1101 会 议室 （五） 网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东大会网络投票系统 网络投票起止时间：自2025 年 6 月 13 日 至2025 年 6 月 13 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为 ...

特此公告。 格科微有限公司董事会 2025年5月23日 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 格科微有限公司（以下简称"公司"）全资子公司格科微电子（上海）有限公 司（以下简称"格科微上海"）作为有限合伙人以自有资金人民币5,000.00万元认 购上海华科致芯创业投资合伙企业（有限合伙）（以下简称"目标基金"或"合伙企 业"）财产份额。该轮募集完成后，合伙企业的认缴出资总额为人民币30,900.00 万元，格科微上海在合伙企业的认缴出资比例为16.18%，具体详见公司于2025 年4月2日在上海证券交易所网站（www.sse.com.cn）披露的《格科微有限公司关 于对外投资暨关联交易的公告》（公告编号：2025-007）。 近日，公司收到基金管理人上海华登高科私募基金管理有限公司通知，目标 基金已在中国证券投资基金业协会完成备案手续并取得私募投资基金备案证明， 备案信息如下： 公司将根据目标基金的后续进展情况，按照有关法律法规的规定和要求，及 时履行信息披露义务。敬请广大投资者理性投资，注意投资风险。 证券代码： ...

Investment Rating - The report maintains a "Buy" rating for the company, expecting a relative increase in stock price of over 20% compared to the benchmark index within the next six months [9][14]. Core Views - The company is projected to achieve revenue of 6.383 billion yuan in 2024, representing a year-on-year growth of 35.90%, with a net profit attributable to shareholders of 187 million yuan, up 287.20% year-on-year [3][12]. - The global smartphone market is expected to rebound in 2024, with an estimated shipment of 1.18 billion units, a growth of approximately 6.8% year-on-year, benefiting the company's mobile CIS product segment [3][4]. - The company is enhancing its product structure with a higher proportion of high-pixel CIS products, which is expected to contribute significantly to revenue growth [3][5]. Company Overview - The latest closing price of the company's stock is 15.20 yuan, with a total market capitalization of 39.5 billion yuan [2]. - The company has a total share capital of 2.601 billion shares, with 1.449 billion shares in circulation [2]. - The asset-liability ratio stands at 65.3%, indicating a moderate level of financial leverage [2]. Financial Projections - Revenue projections for the company are as follows: 8.019 billion yuan in 2025, 10.08 billion yuan in 2026, and 13.009 billion yuan in 2027, with respective growth rates of 25.62%, 25.70%, and 29.06% [12][13]. - The net profit attributable to shareholders is expected to reach 303 million yuan in 2025, 703 million yuan in 2026, and 1.303 billion yuan in 2027, with significant growth rates of 62.22%, 132.07%, and 85.30% respectively [12][13]. Business Segments - The company's mobile CIS business is projected to generate revenue of 3.598 billion yuan in 2024, accounting for 56.39% of total revenue, with a year-on-year growth of 60.44% [3][4]. - The non-mobile CIS segment is also expected to grow, with projected revenue of 1.426 billion yuan in 2024, a year-on-year increase of 17.82% [5]. - The display driver chip business is anticipated to achieve revenue of 1.356 billion yuan in 2024, reflecting a growth of 9.47% [8].

Group 1 - BYD reported August sales of 174,915 new energy vehicles, a year-on-year increase of 184.84% [1] - Cumulative sales from January to August reached 978,795 units, representing a year-on-year growth of 267.31% [1] - The company sold 5,092 new energy passenger vehicles overseas in August [1] Group 2 - Zhongke Electric's subsidiary plans to establish a joint venture with Chongqing Fudi for the production of anode materials, with a registered capital of 1 billion RMB [2] - Zhongke Electric's subsidiary will contribute 650 million RMB, while Chongqing Fudi will contribute 350 million RMB [2] Group 3 - Yuyuan Group intends to transfer 13% of its shares in Jinhuijiu for approximately 1.937 billion RMB, reducing its stake to 25% [3] - The company plans to further reduce its holdings by more than 5% within the next six months [3] Group 4 - Lizhu Group's recombinant COVID-19 fusion protein vaccine has been included in the emergency use for sequential booster immunization [4] Group 5 - Guanghui Energy plans to repurchase shares worth between 800 million and 1 billion RMB to support employee stock ownership plans [5] Group 6 - Cambrian has launched four cloud-based intelligent chips, although mass sales will require a longer time frame and initial technical service investments [7] Group 7 - LePu Medical has received approval from the China Securities Regulatory Commission for the issuance of Global Depositary Receipts (GDRs) and listing on the Swiss Stock Exchange [9] - The GDR issuance will correspond to no more than 180,458,875 new A-shares [9] Group 8 - Fushi Holdings' subsidiary has entered into an exclusive advertising agency cooperation with the Central Radio and Television Station's automotive channel for three years [10] Group 9 - Guangzhou Port's container throughput in August was 1.981 million TEUs, a year-on-year increase of 2.4% [11] - The total cargo throughput for August was 44.788 million tons, a decrease of 0.6% [11] Group 10 - Ningbo Port expects to complete a container throughput of 3.58 million TEUs in August, a year-on-year increase of 10.2% [12] - The total cargo throughput is projected to decline by 3.0% [12] Group 11 - Ming Tai Aluminum reported a 7% year-on-year decrease in aluminum plate and strip sales in August, while aluminum profile sales increased by 47% [13] Group 12 - Electric Power Investment plans to invest in multiple wind and solar projects, with total static investments of 1.585 billion RMB for wind and 538 million RMB for solar [14] Group 13 - Northeast Pharmaceutical has signed a cooperation agreement with MedAbome for the development of the MAb11-22.1 antibody project [19] Group 14 - New Five Feng plans to acquire equity in Tianxin Seed Industry and several other companies for a total price of approximately 2.208 billion RMB [26] Group 15 - Sumeida's subsidiary plans to transfer 100% equity of eight photovoltaic power station project companies, with an estimated transaction value of 657 million RMB [27] Group 16 - *ST Tongzhou intends to acquire 51% equity in Tongtaiwei, fulfilling the capital contribution obligation of 10.2 million RMB [29] Group 17 - Tianyin Holdings' subsidiary plans to invest 120 million RMB in Xundong Xintong to acquire 40% equity [30] Group 18 - Hainan Haiyao plans to publicly transfer 43% equity in Shanghai Lishengte to attract new investors [31] Group 19 - New Asia Process plans to transfer 7.76% of its shares to Xiangcai New Materials at a price of 5.274 RMB per share [32] Group 20 - Lanwei Medical plans to raise no more than 664 million RMB through a private placement for provincial laboratory construction projects [34] Group 21 - Lida New Materials plans to issue convertible bonds to raise no more than 300 million RMB for a new aluminum material project [35] Group 22 - Gekewei has successfully launched its 12-inch CIS integrated circuit project, achieving over 95% yield [51] Group 23 - Baijin Medical's tricuspid valve ring product has received registration approval [52] Group 24 - Shanghai Pharmaceuticals has received approval to initiate Phase I clinical trials for a recombinant anti-CD20 humanized monoclonal antibody [53] Group 25 - Junda Co. has increased the production capacity of its solar cell production base project from 8GW to 10GW [54]

| 序号 | 工作内容 | 持续督导情况 | | --- | --- | --- | | 1 | 建立健全并有效执行持续督导工作制度，并针对具体 | 保荐机构已建立并有效执行了持续 | | | 的持续督导工作制定相应的工作计划 | 督导制度，并制定了相应的工作计 划 | | | 根据中国证监会相关规定，在持续督导工作开始前， | 保荐机构已与格科微签订《保荐协 | | 2 | 与上市公司或相关当事人签署持续督导协议，明确双 | 议》，该协议明确了双方在持续督导 | | | 方在持续督导期间的权利义务，并报上海证券交易所 | 期间的权利和义务，并报上海证券 | | | 备案 | 交易所备案 | | 3 | 通过日常沟通、定期回访、现场走访、尽职调查等方 | 保荐机构通过日常沟通、定期或不 | | | | 定期回访等方式，了解格科微业务 | | | 式开展持续督导工作 | 情况，对格科微开展持续督导工作 | | | 持续督导期间，按照有关规定对上市公司违法违规事 | 年度格科微在持续督导期间未 2024 | | 4 | 项公开发表声明的，应于披露前向上海证券交易所报 | 发生按有关规定需保荐机构公开发 | | | ...

中国国际金融股份有限公司 关于格科微有限公司 首次公开发行股票并在科创板上市的保荐总结报告书 根据中国证券监督管理委员会（以下简称"中国证监会"）于2021年6月16日签发的 证监许可[2021]2049号文《关于同意格科微有限公司首次公开发行股票注册的批复》， 格科微有限公司（以下简称"格科微"或"公司"）在境内首次公开发行249,888,718股 人民币普通股A股股票，每股发行价格为人民币14.38元，募集资金总额为人民币 3,593,399,764.84元。 中国国际金融股份有限公司（以下简称"中金公司"或"保荐机构"）作为公司首次公 开发行股票并在科创板上市的保荐机构，根据《上海证券交易所科创板股票上市规则》 的相关规定，中金公司的持续督导期间为2021年8月18日至2024年12月31日。截至2024年 12月31日，前述持续督导期限已届满，公司首次公开发行的结余募集资金6,511,077.93元 已全部用于永久补充流动资金，募集资金专户已销户。 中金公司根据《证券发行上市保荐业务管理办法》《上海证券交易所上市公司自律 监管指引第11号——持续督导》《上海证券交易所科创板股票上市规则》等有关法律法 ...

中国国际金融股份有限公司 关于格科微有限公司 2024 年度持续督导工作现场检查报告 上海证券交易所： 根据《上海证券交易所科创板股票上市规则》等有关法律、法规的规定，中国国际 金融股份有限公司（以下简称"保荐机构"、"中金公司"）作为正在履行格科微有限公司 （以下简称"格科微"、"公司"）持续督导工作的保荐机构，对公司 2024 年度的规范运作 情况进行了现场检查，现就现场检查的有关情况报告如下： 一、本次现场检查的基本情况 （五）现场检查内容：公司治理及内部控制、信息披露、独立性、与关联方的资金 往来、募集资金使用情况、关联交易、对外担保、重大对外投资及公司经营状况等。 （六）现场检查手段： 1、对公司高级管理人员等有关人员进行访谈； （一）保荐机构：中国国际金融股份有限公司 （二）保荐代表人：孙远、姚迅 （三）现场检查时间：2025 年 4 月 15 日 2、查阅公司公告、公司治理文件、公司定期报告及重大资金往来凭证等底稿文件； （四）现场检查人员：孙远、南堰 3、查阅公司募集资金使用凭证、募集资金专户银行对账单等资料； 4、查阅公司上市以来建立或更新的有关内控制度文件； 5、核查公司上市以来发生的关联 ...

证券代码：688728 证券简称：格科微 公告编号：2025-017 格科微有限公司 关于召开 2024 年度暨 2025 年第一季度业绩说明会的 公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 会议召开时间：2025 年 5 月 13 日(星期二)上午 09:00-10:00 会议召开地点：上海证券交易所上证路演中心（网址： https://roadshow.sseinfo.com/） （二） 会议召开地点：上海证券交易所上证路演中心（网址： https://roadshow.sseinfo.com/） （三） 会议召开方式：上证路演中心网络互动 三、 参加人员 董事长：赵立新 会议召开方式：上证路演中心网络互动 投资者可于 2025 年 5 月 6 日(星期二) 至 5 月 12 日(星期 一)16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或 通过公司邮箱 yjsmh@gcoreinc.com 进行提问。公司将在说明会上对 投资者普遍关注的问题进行回答。 格科微有限公司（以下简称"公 ...

Group 1: Company Insights - Huangma Technology's export sales growth exceeded 30% in Q1 2025, with minimal impact from US tariff policies. The increase in gross margin is attributed to higher production and sales volumes, along with a decrease in epoxy propane prices. The company plans to expand production capacity and has a stable dividend policy, committing to cash dividends exceeding 30% of net profit for 2024 [1] - Lianchuang Optoelectronics reported significant revenue growth in Q1 2025 due to the gradual release of large orders. The company expects a substantial reduction in losses for the year, driven by cost control and digital transformation efforts. The development of high-power lightweight pump sources and laser technology is underway, with a focus on optimizing asset quality in the backlight source industry [2] - GeKong Microelectronics achieved a revenue of 6.383 billion yuan in 2024, a year-on-year increase of 35.9%, with net profit rising by 287.2%. The company is confident in the mainstream adoption of high-pixel single-chip technology and is expanding its product lines in non-mobile sectors [3] - Pumen Technology experienced negative revenue growth in domestic business due to respiratory disease outbreaks and payment reform impacts. However, international business remains stable, and the company is focusing on product development and cost control [4] - Xiangpiaopiao faced challenges in its milk tea business in Q4 2024 and Q1 2025 due to external conditions and internal strategy adjustments. The company is launching new products and optimizing its marketing strategies to enhance brand visibility and sales [5] Group 2: Market Trends and Strategies - The market for Huangma Technology is perceived to have significant growth potential, with no apparent ceiling in sight. The company is leveraging AI technology in R&D and production processes [1] - Lianchuang Optoelectronics is focusing on optimizing its product structure and enhancing cost management to improve profitability in the backlight source sector [2] - GeKong Microelectronics is actively seeking non-US solutions to mitigate trade war impacts and is confident in the growth of its high-pixel product lines [3] - Pumen Technology is enhancing its international marketing structure and focusing on localizing operations to strengthen its global presence [4] - Xiangpiaopiao is exploring new product categories and channels to adapt to market demands and improve sales performance [5]